Info
Histologic Transformation of follicular lymphoma
-
~3%/y risk of transformation from FL to DLBCL,
-
rapid nodal enlargement & rising LDH, ± systemic symptoms
-
Bx is required to diagnose transformation.
-
PET may be useful in determining a site for bx.
-
SUV values >10–13 suggest transformation (Ann Oncol 2009;20:508)
-
Transformation to DLBCL in a previously untreated pt treated similar to de novo DLBCL
-
If histologic transformation occurs after prior chemotherapy, consider consolidation w/ high dose therapy and autologous stem cell rescue in chemosensitive disease